// App-Quantinova.ai

1018 : Safety of Palbociclib in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoma: A Children’s Oncology Group Pilot Study

Researchers

Presenter

  • Elizabeth A. Raetz

Principal Investigators

  • David T. Teachey

  • Charles Minard

  • Xiaowei Liu

  • Robin Norris

  • Joel Reid

  • Thalia Beeles

  • Lia Gore

  • Elizabeth Fox

  • Mignon L. Loh

  • Brenda J. Weigel

  • William L. Carroll

Medical Centers

  • Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY

  • Center for Childhood Cancer Research, Childrens Hospital of Philadelphia, Philadelphia, PA

  • Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX

  • Children's Oncology Group, Monrovia, CA

  • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

  • Mayo Clinic, Rochester, MN

  • Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado and Children's Hospital Colorado, Aurora, CO

  • St. Jude Children's Research Hospital, Memphis, TN

  • Department of Pediatrics, Division of Hematology-Oncology, University of California, San Francisco and Benioff Children's Hospital, San Francisco, CA

  • University of Minnesota, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Palbociclib

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Cohort

Phase

  • NA

Study Id's

  • NCT03792256

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved